期刊论文详细信息
Revista Brasileira de Hematologia e Hemoterapia
Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia
关键词: Patient compliance;    Therapeutics;    Leukemia, chronic myeloid;    BCR-ABL positive;   
DOI  :  10.5581/1516-8484.20140014
来源: DOAJ
【 摘 要 】

Treatment of chronic myeloid leukemia with BCR-ABL tyrosine kinase inhibitors requires full adherence in order to maximize the likelihood of achieving optimal responses, and to minimize healthcare costs. In this article, we review some of the methods available for assessing compliance, the main consequences of nonadherence on treatment outcomes, major factors commonly associated with poor compliance, a few successful measures for improving adherence and the most accepted recommendations for proactively managing adverse events.

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:0次